What is the initial evaluation and treatment approach for a patient presenting with pleural effusion?

Initial Evaluation and Treatment of Pleural Effusion

Begin with chest radiography or CT chest with IV contrast as the initial imaging study, followed by ultrasound-guided diagnostic thoracentesis using a 21-gauge needle to obtain pleural fluid for comprehensive analysis including protein, LDH, pH, cytology, Gram stain, AAFB stain, and microbiological culture in both sterile vials and blood culture bottles. 1, 2, 3

Initial Clinical Assessment

Skip thoracentesis only if bilateral effusions occur in the clear clinical context of heart failure, cirrhosis, or nephrotic syndrome with typical features—otherwise proceed to sampling. 2, 4

Look specifically for:

• Dyspnea out of proportion to effusion size (suggests pulmonary embolism) 2
• Pleuritic chest pain (75% of PE-related effusions) 2
• Recent pneumonia with fever (parapneumonic effusion/empyema) 1
• Constitutional symptoms (weight loss, malaise suggest malignancy) 5
• Drug history (numerous medications cause exudative effusions) 2

Imaging Algorithm

First-Line Imaging

• Chest radiography OR CT chest with IV contrast are equivalent initial options 1
• If CT is performed, acquire images 60 seconds post-contrast to optimize pleural visualization 1

Mandatory Pre-Procedure Ultrasound

• Perform thoracic ultrasound on every patient before any pleural procedure 3, 6
• Ultrasound guidance reduces pneumothorax risk from 8.9% to 1.0% 3, 6
• Ultrasound identifies effusion size, character, pleural nodularity (malignancy), and loculations 3

Diagnostic Thoracentesis Technique

Procedure Specifics

• Use 21-gauge fine-bore needle with 50 ml syringe 2, 3
• Limit fluid removal to maximum 1.5 liters to prevent re-expansion pulmonary edema 5, 3, 6
• Always use ultrasound guidance 3, 6

Mandatory Pleural Fluid Tests

Send fluid for ALL of the following 2, 3:

• Protein and LDH (to apply Light's criteria if protein 25-35 g/L)
• pH measurement (critical for parapneumonic effusions)
• Cytology (60% sensitivity for malignancy)
• Gram stain and culture
• AAFB stain and TB culture
• Blood culture bottles (increases microbiological yield)

Interpreting Results

Apply Light's criteria to differentiate exudate from transudate when pleural fluid protein is 25-35 g/L: 2

• Pleural/serum protein ratio >0.5, OR
• Pleural/serum LDH ratio >0.6, OR
• Pleural LDH >2/3 upper limit of normal serum LDH

Key diagnostic thresholds for exudates: 7, 4

• LDH >1000 IU/L: empyema, parapneumonic effusion, or rheumatoid pleuritis
• Lymphocytes ≥80%: tuberculosis or malignancy
• pH <7.2: complicated parapneumonic effusion requiring drainage
• Eosinophils >10%: air or blood in pleural space, drug reaction, or parasitic infection

Treatment Based on Effusion Type

Transudative Effusions

• Treat the underlying condition (heart failure, cirrhosis, nephrotic syndrome) 2, 6
• Therapeutic thoracentesis only if symptomatic while treating underlying cause 6

Exudative Effusions

Parapneumonic Effusion/Empyema

• If pH <7.2, glucose low, or purulent appearance: immediate chest tube drainage required 6, 4
• Use small-bore chest tube (14F or smaller) 6
• Hospitalize all patients for IV antibiotics covering respiratory pathogens 6
• Consider tissue plasminogen activator/DNase therapy if loculated 4

Malignant Pleural Effusion

For symptomatic patients: 3, 6

1. Perform large-volume thoracentesis first (up to 1.5L) to assess symptom relief and lung expandability
2. If lung expands completely: offer either indwelling pleural catheter OR chemical pleurodesis (talc 4-5g)
3. If non-expandable lung or failed pleurodesis: use indwelling pleural catheter only

For asymptomatic malignant effusions: observation only—do not perform therapeutic interventions 6

Chemotherapy-responsive tumors (small-cell lung cancer, breast cancer, lymphoma): 6

• Prioritize systemic chemotherapy over local pleural interventions
• Consider pleurodesis only if chemotherapy fails or is contraindicated

Tuberculosis

• If lymphocyte-predominant effusion (≥80%) with positive AAFB or TB culture: initiate anti-TB therapy 7
• Consider pleural biopsy if TB suspected but fluid analysis negative 8, 9

Critical Pitfalls to Avoid

• Never remove >1.5L in single thoracentesis (re-expansion pulmonary edema risk) 5, 3, 6
• Never attempt pleurodesis without confirming lung expandability on post-thoracentesis chest X-ray 6
• Never perform intercostal tube drainage without pleurodesis (100% recurrence rate at 1 month) 5, 6
• Never delay systemic therapy in chemotherapy-responsive tumors for local pleural treatment 6
• Do not routinely perform bronchoscopy unless hemoptysis, atelectasis, or suspected endobronchial obstruction present 8

When to Obtain Pleural Tissue

Refer to pulmonology for pleural biopsy (ultrasound/CT-guided, closed needle biopsy, or thoracoscopy) if: 2

• Cytology negative but malignancy suspected
• Exudative effusion remains undiagnosed after initial fluid analysis
• TB suspected but fluid studies negative
• Contrast-enhanced CT thorax should be performed with fluid present to visualize pleura and guide biopsy site 2